Terms: = Testicular cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Diagnosis
4 results:
1. Long-term response to camrelizumab in a pretreated metastatic mixed testicular germ-cell tumor patient with co-mutations in DNA damage-repair genes.
Zhang H; Jiang D; Meng E; Zhao M; Niu B
Immunotherapy; 2023 Jan; 15(1):17-25. PubMed ID: 36647794
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.
Ji YS; Park SH
Cancer Res Treat; 2021 Jul; 53(3):874-880. PubMed ID: 33285049
[TBL] [Abstract] [Full Text] [Related]
3. Severe Epididymo-Orchitis and Encephalitis Complicating Anti-pd-1 Therapy.
Quach HT; Robbins CJ; Balko JM; Chiu CY; Miller S; Wilson MR; Nelson GE; Johnson DB
Oncologist; 2019 Jul; 24(7):872-876. PubMed ID: 30936376
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Response of a Patient to Anti-pd-1 Immunotherapy and the Immune Landscape of testicular Germ Cell Tumors.
Shah S; Ward JE; Bao R; Hall CR; Brockstein BE; Luke JJ
Cancer Immunol Res; 2016 Nov; 4(11):903-909. PubMed ID: 27638840
[TBL] [Abstract] [Full Text] [Related]